Jeff Haney

1.4k citations
11 papers · 1.1k · 1 hit paper · h-index 5

Impact in

Papers in

Jeff Haney

11 papers receiving 1k citations

Jeff Haney's Hit Papers

Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer 2018 · 775 citations
7750+2+5Years since publication250500750

Peers

Jeff Haney
Comparison fields: 5 of 55
  • Pulmonary and Respiratory Medicine 784
  • Immunology 138
  • Drug Discovery 1
  • Cancer Research 41
  • Toxicology 13
Replace S. Polyakov with:
S. Polyakov Belarus
Olga Valota United States
Binh Nguyen United States
Luigi Portalone Italy
Gina Z. D’Amato United States
Giovanni Palazzolo Italy
Maria Marples United Kingdom
Lynda M. Pyle United Kingdom
Lajos Géczi Hungary
Eduardo J. Pennella United States
Jeff Haney relative to S. Polyakov Belarus S. Polyakov's profile →
Citations per field
00.5×2×3×4×5×
S. Polyakov · 1×
Citations per year

Countries citing papers authored by Jeff Haney

Since Specialization
Citations

This map shows the geographic impact of Jeff Haney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Haney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Haney more than expected).

Fields of papers citing papers by Jeff Haney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Haney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Haney. The network helps show where Jeff Haney may publish in the future.

Co-authors

The 25 scholars most cited alongside Jeff Haney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeff Haney Line = papers co-authored together Jeff Haney links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer
Hit paper breakdown →
2018775
2 2018121
3 200379
4 200377
5 20177
6 20163
7 20183
8 20162
9 20172
10 20192
11 20191

About Jeff Haney

Jeff Haney is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (784 citations), Immunology (138 citations), Drug Discovery (1 citation), Cancer Research (41 citations) and Toxicology (13 citations). Jeff Haney has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Sam Salek, Andrew Yule Finlay, Kenneth B. Gordon, Akshay K. Vaishnaw, Alan Menter, John T. O'Gorman, Kathryn Ann Gold, Scott N. Gettinger, D. Ross Camidge and Corey Jay Langer. Their work appears in journals such as Annals of Oncology, New England Journal of Medicine, Journal of Clinical Oncology, Dermatology and Archives of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact